The current COVID-19 pandemic is an exemplar of how Decision Intelligence can be applied in a real-world situation, where businesses need to make informed, high-stakes decisions about which mitigation strategies to invest in. But, to know they are making the right decisions around the novel coronavirus, they need to explore volumes of data, multiple epidemiological and infection models, and work out how those apply to their particular workspace. In most cases it's just easier to apply the minimum regional government guidance and hope this will be sufficient.
Currently progressing through our DecisionLab development cycle and funded by Innovate UK, we have created an application to be used to assess new building designs and their associated Bio-Safety
We have a working advanced prototype created by modelling and simulating an event at the Edinburgh international Conference Centre. (EICC)
WorkSafeAI® , has four key components, brought together by technology advances and an unique approach to simulation.
We ingest into WorkSafeAI® the 3D Architecture model of proposed facilities produced by architects and building designers.
We apply human agent modelling to the proposed use of the facilities, opening times, no of users, zones of work etc. These Agent Models inform the human movement simulation within the proposed facility.
We take leading edge global research of the COVID-19 virus and have built a holistic model to simulate COVID-19 emission, transmission and infection within the modelled workplace.
We include computational fluid dynamics (air flow or aerodynamics) simulation within the model, informed through building design engineering features such as Heating, Ventilation and Air Conditioning (HVAC). Air flow has significant impact on the overall airborne load, where it accumulates and thus hot-zone risks of high pathogen load.
WorkSafe.AI® provides a unique opportunity to inform how we design buildings of the future, re-assess how we use existing buildings or re-purpose facilities to put health and well-being at the centre of our decisions, by minimising the risk of disease transmission.
Get 10% off your first purchase when you sign up for our newsletter!